This message contains images. If you don't see images, click here to view.
Advertise in this news brief.



Text Version   RSS   Subscribe   Unsubscribe   Archive   Media Kit |  Histology Marketplace:     

Home   History   Meeting Calendar   Career Center   Certification   Contact Us    


Replace Messy Ice Baths

Cool to -60C. Heat to +150C. Designed for laboratory use, TECA cold/hot plates offer convenient thermal control of samples in histology and life sciences applications.



 




NSH NEWS

Making the Case for Case Study Presentations in the Histology Laboratory or Histotech Program
NSH
On March 5, join Nancy Ramirez, MT(ASCP) from William Beaumont Hospital for the next Histology Leader Webinar focusing on advantages of utilizing and presenting clinical case studies in the anatomic and clinical laboratory setting. In addition, this webinar will provide helpful tips and example tools to assist in the development, delivery and evaluation (or grading) of the case presentation. Click here to register today.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE  




Histotechnology Professionals Day activities and celebrations
NSH
March 10 is coming up fast — are you ready to celebrate the 5th Annual Histotechnology Professionals Day? NSH is ready! Our website features celebration ideas and items you can purchase to help celebrate the day. In honor of our members NSH is sponsoring a free 30-minute educational webinar series for NSH Members during the weeks of March 10-April 27. We will start the celebration with HPD and keep on celebrating through Lab Week. These webinars feature top rated NSH speakers teaching topics that span safety to troubleshooting to quality management — there is a topic for everyone! NSH will also be hosting a histotechnology themed scavenger hunt March 10-14. The top prize is a $250 Visa Gift card! Click here to start your celebration plans for the 2014 Histotechnology Professionals Day.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


SPONSORED CONTENT


TOP STORIES


Tiny motors that fit inside human cells could someday treat disease
Gigaom
Tiny synthetic motors created at Pennsylvania State University are the first to fit inside living human cells, where they can modify the cell's structure or even kill it. The advancement opens up new possibilities for researchers to develop disease treatments.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Rare disease in women pulls together community of researchers and patients
Medical Xpress
It's not cancer, but it grows and spreads to distant organs. It's not malignant, but women die when it destroys their lungs. It has no cure, but scientists, physicians and patients are converging to change that. Lymphangioleiomyomatosis — LAM for short — is a rare disease in which abnormal, smooth muscle-like cells grow out of control, usually in the kidney, lymph nodes and lungs. It develops almost exclusively in women during their childbearing years.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PRODUCT SHOWCASE
  Reduce Cost with Same Quality

GBI Labs produces the largest selection of secondary detection kits. We provide free samples to 1st time users. Staining with our kits results in similar or better sensitivity than other detection kits on the market. Some 110mL kits cost as little as $700.00 and 18 ml kit > $300.00.
 


Researchers generate new neurons in brains, spinal cords of living adult mammals
UT Southwestern Medical Center via Bioscience Technology
UT Southwestern Medical Center researchers created new nerve cells in the brains and spinal cords of living mammals without the need for stem cell transplants to replenish lost cells. Although the research indicates it may someday be possible to regenerate neurons from the body’s own cells to repair traumatic brain injury or spinal cord damage or to treat conditions such as Alzheimer’s disease, the researchers stressed that it is too soon to know whether the neurons created in these initial studies resulted in any functional improvements, a goal for future research.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Experimental treatment eradicates acute leukemia in mice
UCLA via R&D Magazine
A diverse team of scientists from UCLA's Jonsson Comprehensive Cancer Center has developed an experimental treatment that eradicates an acute type of leukemia in mice without any detectable toxic side effects. The drug works by blocking two important metabolic pathways that the leukemia cells need to grow and spread. Elements of metabolism called biosynthetic pathways allow cells to synthesize chemicals, called nucleotides, that they need to survive. When these nucleotide pathways are blocked by drug molecules, cancer cell growth can be halted, which can trigger cell death.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


  PRODUCT SHOWCASES
Empowering Science with Color Integrity

Datacolor CHROMACAL™ standardizes color reproduction in digital brightfield images.

• Delivers a consistent, reliable basis for evaluation, communication, quantification, documentation and publication
• Includes image and monitor calibration software, along with a proprietary color calibration slide
• Integrates into existing imaging workflow
• Compatible with most microscopes, scientific cameras and acquisition software

LEARN MORE
ergoCentric Laboratory Seating

Visit LabStorage System’s updated website to view details about this new laboratory seating with specially formulated Infection Control coating. Non-porous and easily disinfected, this moisture proof coating is anti-bacterial, anti-fungal and stain resistant. more



To find out how to feature your company in Under the Microscope and other advertising opportunities, Contact Geoffrey Forneret at 469.420.2629

More info


IN THE NEWS


Can aspirin fight cancer?
The Boston Globe
Aspirin, a medicine cabinet staple for fighting heart attacks and headaches, is also a powerful weapon against cancer, a growing body of research shows. The groups most likely to benefit from aspirin’s anti-cancer powers, research suggests, are those at extra risk for colon cancer and people between ages 50 and 75, said Dr. Andrew Chan, a gastroenterologist at Massachusetts General Hospital. Those older than 75 are at higher risk for aspirin’s side effects, and people younger than 50 stand to benefit less from its cancer-fighting effects, he said.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Malignant melanoma: Diagnosis and treatment progress
By Rosemary Sparacio
Immunology has been in the forefront and progress in the area of skin cancer — particularly malignant melanoma — and has shown great promise. Melanoma is the sixth-most common cancer in the U.S., and the most common fatal malignancy in young adults. Currently, about 1 in 50 people will be diagnosed with melanoma. In the 1960s, it was 1 in 600. Two independent studies are being conducted using two different kinds of vaccines developed to treat malignant melanoma.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE
Looking for similar articles? Search here, keyword RESEARCH.


Vitamin A may help boost immune system to fight tuberculosis
UCLA
Tuberculosis is a major global problem, affecting 2 billion people worldwide and causing an estimated 2 million deaths annually. Western countries are once again tackling the disease, with recent outbreaks in Los Angeles and London. The rise of drug-resistant TB, called a "ticking time bomb" by the World Health Organization, and the high cost of fighting the disease highlight the need for new approaches to treatment.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


TRENDING ARTICLES
Missed last week's issue? See which articles your colleagues read most.

    Latest research offers promise in detection of pancreatic cancer (By Rosemary Sparacio)
NSH Feb. 26 laboratory webinar with Dr. Cecilia Yeung from Fred Hutchinson Cancer Research Center (NSH)
Dense breast tissue drives early stages of cancer, new study finds (Medical News Today)

Don't be left behind. Click here to see what else you missed.
 

Under the Microscope
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Ashley Whipple, Senior Content Editor, 469.420.2642   
Contribute news

This edition of Under the Microscope was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here -- it's free!
Recent issues






7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063